Evidence map›Paper›PMID 32433479›Full record

Observational studyScientific reports2020

Integration of whole-body [

Klev Diamanti, Robin Visvanathar, Maria J Pereira, Marco Cavalli, Gang Pan, Chanchal Kumar, Stanko Skrtic, Ulf Risérus, Jan W Eriksson, Joel Kullberg and 3 more

Erratum issuedOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Phenomic Imaging.Phenomics (Cham, Switzerland) · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Klev Diamanti *Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Robin Visvanathar *Department of Surgical Sciences, section of Radiology, Uppsala University, Uppsala, Sweden.
Maria J PereiraDepartment of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
Marco CavalliScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Gang PanScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Chanchal KumarTranslational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Stanko SkrticPharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden.
Ulf RisérusDepartment of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Jan W ErikssonDepartment of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
Joel KullbergDepartment of Surgical Sciences, section of Radiology, Uppsala University, Uppsala, Sweden.
Jan KomorowskiScience for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Claes WadeliusScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Håkan AhlströmDepartment of Surgical Sciences, section of Radiology, Uppsala University, Uppsala, Sweden. hakan.ahlstrom@radiol.uu.se.
Uppsala University · SEScience for Life Laboratory · SEAntaros Medical (Sweden) · SEAstraZeneca (Sweden) · SEInstitute of Computer Science · PLSahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alteration of various metabolites has been linked to type 2 diabetes (T2D) and insulin resistance. However, identifying significant associations between metabolites and tissue-specific phenotypes requires a multi-omics approach. In a cohort of 42 subjects with different levels of glucose tolerance (normal, prediabetes and T2D) matched for age and body mass index, we calculated associations between parameters of whole-body positron emission tomography (PET)/magnetic resonance imaging (MRI) during hyperinsulinemic euglycemic clamp and non-targeted metabolomics profiling for subcutaneous adipose tissue (SAT) and plasma. Plasma metabolomics profiling revealed that hepatic fat content was positively associated with tyrosine, and negatively associated with lysoPC(P-16:0). Visceral adipose tissue (VAT) and SAT insulin sensitivity (K

Indexed as

Insulin ResistanceAgedAmino Acids, Branched-ChainCase-Control StudiesDiabetes Mellitus, Type 2FemaleFluorodeoxyglucose F18Glucose Clamp TechniqueHumansInsulinIntra-Abdominal FatLipid MetabolismLiverLysophospholipidsMagnetic Resonance ImagingMaleAmino Acids, Branched-ChainFluorodeoxyglucose F18InsulinLysophospholipids

Identifiers

PMID32433479
PMCPMC7239946
OpenAlexW3027714954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.